InMed Pharmaceuticals Inc.INMNASDAQ
Loading
| Metric | Jun 21 | Jun 22 | Jun 23 |
|---|---|---|---|
| Revenue | 0 | 1 | 4 |
| Gross Profit | 0 | 1 | 1 |
| Operating Income | -12 | -14 | -8 |
| Net Income | -13 | -19 | -8 |
| EBITDA | -12 | -13 | -8 |
| EPS Diluted | -938.91 | -21350.51 | -86.00 |
| Metric | Jun 21 | Jun 22 | Jun 23 |
|---|---|---|---|
| Cash & Equivalents | 9 | 8 | 12 |
| Total Current Assets | 10 | 12 | 15 |
| Total Assets | 12 | 16 | 19 |
| Total Current Liabilities | 3 | 4 | 3 |
| Total Liabilities | 3 | 5 | 3 |
| Total Equity | 9 | 12 | 16 |
| Total Debt | 0 | 1 | 1 |
| Net Debt | -9 | -7 | -11 |
| Metric | Jun 21 | Jun 22 | Jun 23 |
|---|---|---|---|
| Operating Cash Flow | -10 | -16 | -7 |
| Capital Expenditure | -0 | -0 | -0 |
| Free Cash Flow | -10 | -16 | -7 |
| Stock-Based Comp | 1 | 1 | 0 |
| Net Change in Cash | 2 | -1 | 3 |